Clinical trial
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the…
NCT00151788 · Daiichi Sankyo, Industry · Terminated
Key facts
| NCT number | NCT00151788 |
|---|---|
| Title | Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE. |
| Official title | A Randomized, Double-blind, Stratified, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Heterozygous Familial Hypercholesterolemia and Carotid Atherosclerosis Using Carotid Ultrasound… |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Heterozygous Familial Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Pactimibe sulfate |
| Enrollment | 796 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Jan 18, 2012 |
| Countries | Canada, Israel, Netherlands, Norway, South Africa, Spain, Sweden, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: